Extended Immunological Analysis of Two Phase 1 Clinical Trials of MVA-BN®-HER2 in HER-2 Overexpressing Metastatic Breast Cancer Patients Fatema Legrand1, Rachel Owen1, Michael Delacher1, Anh-Tuan Nguyen1, Ulf Reimer2,

First Page		Document Content
Date: 2013-03-12 10:48:04 T cells Immunology PD-1 Trastuzumab HER2/neu CD25 Natural killer cell Immunotherapy Antigen Biology Immune system Anatomy		Extended Immunological Analysis of Two Phase 1 Clinical Trials of MVA-BN®-HER2 in HER-2 Overexpressing Metastatic Breast Cancer Patients Fatema Legrand1, Rachel Owen1, Michael Delacher1, Anh-Tuan Nguyen1, Ulf Reimer2, Add to Reading List Source URL: www.jpt.com Download Document from Source Website File Size: 376,93 KB Share Document on Facebook

	Onerahtokha is I:waks (Ee-woks) Cancer Prevention Month What is Cancer? Cancer is a type of illness where some of the body’s cells grow too quickly. This can cause a lump in the body that isn’t supposed to be there. DocID: 1vhnw - View Document
	VIRUSES PACKING AND CELL INFECTION Reagents OPTIMEM. HEK 293 T cells. DocID: 1uSZz - View Document
	Article Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits Graphical Abstract DocID: 1uHSl - View Document
	Evaluation of Interferon-gamma-Producing T Cells DocID: 1uFKZ - View Document
	Ganglion Cell Adaptability: Does the Coupling of Horizontal Cells Play a Role? Karin Dedek1, Chethan Pandarinath2, Nazia M. Alam3, Kerstin Wellershaus4, Timm Schubert1, Klaus Willecke4, Glen T. Prusky3, Reto Weiler1, She DocID: 1uDKf - View Document